Catégorie : Ressources Documentaires

A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects, G. Morrison et al., , 2019

A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects. G. Morrison, J. Crockett, G. Blakey, K. Sommerville Clinical Pharmacology in Drug Development, 2019, PMID : 30791225, DOI : 10.1002/cpdd.665 Abstract GW Pharmaceuticals' formulation of highly purified cannabidiol oral solution is approved in the United States for seizures associated with Lennox-Gastaut and Dravet syndromes in patients aged ≥2 years, for which clobazam, stiripentol, and valproate are commonly used antiepileptic drugs. This open-label, fixed-sequence, drug-drug interaction, healthy volunteer trial investigated the impact of cannabidiol on steady-state pharmacokinetics of clobazam (and N-desmethylclobazam), stiripentol, and valproate; [...]

Lire la suite

Variétés de Cannabis, Docteur Ethan Russo, IACM

Variétés de Cannabis: Par Docteur Ethan Russo http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=172&lng=fr   Les consommateurs de cannabis ont souvent indiqué que les différentes variétés de cannabis produisent des effets variables, que se soit concernant les effets psychoactifs ou les bénéfices thérapeutiques. Les variétés sont généralement désignées comme étant soit Sativa, soit Indica, soit hybrides. Or, ces noms, d’un point de vue commercial, prêtent à confusion. Pour cette raison, la communauté scientifique s’est concentrée sur le Tétrahydrocannabinol (THC) qu’elle considérait comme la principale variable et la seule d’importance. En parallèle, jusqu’à très récemment, les croisements sélectifs des variétés de cannabis, destiné à l’usage récréatif ou à l’usage thérapeutique, [...]

Lire la suite

Psilocybin with psychological support for treatment-resistant depression : six-month follow-up, R. L. Carhart-Harris et al., 2018

Psilocybin with psychological support for treatment resistant depression : six-month follow-up R. L. Carhart-Harris, M. Bolstridge, C. M. J. Day, J. Rucker, R. Watts, D. E. Erritzoe,  M. Kaelen,  B. Giribaldi, M. Bloomfield, S. Pilling, J. A. Rickard, B. Forbes,  A. Feilding,  D. Taylor, H. V. Curran, D. J. Nutt Psychopharmacology, 2017 https://doi.org/10.1007/s00213-017-4771-x   Abstract : Rationale : Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. Objectives : Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. Methods : Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant [...]

Lire la suite

Psychedelics and hypnosis : Commonalities and therapeutic implications, Clément E. Lemercier, Devin B. Terhune, 2018

Psychedelics and hypnosis : Commonalities and therapeutic implications Clément E. Lemercier, Devin B. Terhune Journal of Psychopharmacology, 2018, 32, 7, 732-740. DOI : 10.1177/0269881118780714   Abstract Background : Recent research on psychedelics and hypnosis demonstrates the value of both methods in the treatment of a range of psychopathologies with overlapping applications and neurophenomenological features. The potential of harnessing the power of suggestion to influence the phenomenological response to psychedelics toward more therapeutic action has remained unexplored in recent research and thereby warrants empirical attention. Aims : Here we aim to elucidate the phenomenological and neurophysiological similarities and dissimilarities between psychedelic states and hypnosis in order to revisit [...]

Lire la suite

L’amende forfaitaire pour usage de drogues doit être censurée par le Conseil constitutionnel

L’amende forfaitaire pour usage de drogues doit être censurée par le Conseil constitutionnel Dix-neuf organisations demandent aux Sages de censurer l’article 58 de la loi de programmation 2018-2022 de réforme pour la justice qui est contraire à la Constitution. Cet article prévoit que le délit d’usage de stupéfiants peut désormais faire l’objet d’une amende forfaitaire de 200€. Monsieur le Président du Conseil constitutionnel, Mesdames et Messieurs les Membres du Conseil constitutionnel 2, rue Montpensier 75001 Paris. Paris, le 28 février 2019 Objet : Affaire n° 2019-778 DC Monsieur le Président du Conseil constitutionnel, Mesdames et Messieurs les membres du Conseil constitutionnel, Nous, organisations non-gouvernementales françaises, vous adressons ce jour notre [...]

Lire la suite

Cannabinoid-Based Therapies and Brain Development : Potential Harmful Effect of Early Modulation of the Endocannabinoid System, P. Schonhofen et al., 2018.

Cannabinoid-Based Therapies and Brain Development : Potential Harmful Effect of Early Modulation of the Endocannabinoid System. Patricia Schonhofen, Ivi Juliana Bristot, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Antonio Waldo Zuardi, Richard B. Parsons, Fabio Klamt CNS Drugs, 2018, 32 (Suppl 1), 1-16 https///doi.org/10.1007/s40263-018-0550-4 Abstract : The endocannabinoid retrograde signaling pathway is widely expressed in the central nervous system, where it plays major roles in regulating synaptic plasticity (excitatory and inhibitory) through long-term potentiation and long-term depression. The endocannabinoid system (ECS) components-cannabinoid receptors, endocannabinoids and synthesis/degradation enzymes-are expressed and are functional from early developmental stages and throughout adolescent cortical development, regulating progenitor cell fate, neural [...]

Lire la suite

Cannabidiol attenuates deficits of visuospatial associative memory induced by D9tetrahydrocannabinol, M. Jerry Wright Jr et al., 2013

Cannabidiol attenuates deficits of visuospatial associative memory induced by D9tetrahydrocannabinol M. Jerry Wright Jr, Sophia A. Vandewater and Michael A. Taffe Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA British Journal of Pharmacology, 2013, 170, 1365–1373   BACKGROUND AND PURPOSE Recent human studies suggest that recreational cannabis strains that are relatively high in cannabidiol (CBD) content produce less cognitive impairment than do strains with negligible CBD and similar D9tetrahydrocannabinol (THC) content. Self-selection in such studies means it is impossible to rule out additional variables which may determine both cannabis strain selection and basal cognitive performance level. Controlled laboratory studies can [...]

Lire la suite

Neurobiology of Disease : Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults, Barbara J. Weiland et al., 2015

Neurobiology of Disease : Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults Barbara J. Weiland, Rachel E. Thayer, Brendan E. Depue, Amithrupa Sabbineni, Angela D. Bryan, and Kent E. Hutchison Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, Colorado 80309, Department of Psychological and Brain Sciences, University of Louisville, Louisville, Kentucky 40292 The Journal of Neuroscience, 2015, 35, 4, 1505–1512. DOI : 10.1523/JNEUROSCI.2946-14.2015   Abstract : Recent research has suggested that marijuana use is associated with volumetric and shape differences in subcortical structures, including the nucleus accumbens and amygdala, in a dose-dependent fashion. Replication of such results in well controlled [...]

Lire la suite

Qu’est-ce que le cannabinol (CBN) ? Le Cannabiste.com, 2019

Qu’est-ce que le cannabinol ? Les CBN est le Cannabinoïde responsable d’un meilleur sommeil Aujourd’hui , les capacités de développement et de recherche dans le secteur du cannabis reconnaisse que le facteur responsable du sommeil est le cannabinoïde communément appelé le CBN. Il vous reste quelques fleurs de canna dans une vieille boite ? Certes, il se pourrait qu’il soit beaucoup moins fort en THC. Mais il a de forte chance que votre contenu est chargé en CBN  Qu’est ce que le CBN  ? Le CBN se forme à partir du THC ” rance ” ou ” pas frais ”. Il a des avantages [...]

Lire la suite

Striking lung cancer response to self-administration of cannabidiol: A case report and literature review, Josep Sulé-Suso et al., 2019

Striking lung cancer response to self-administration of cannabidiol : A case report and literature review Josep Sulé-Suso, Nick A Watson, Daniel G van Pittius, Apurna Jegannathen SAGE Open Medical Case Reports, 2019, 7, 1-4.   Abstract : In spite of new drugs, lung cancer is associated with a very poor prognosis. While targeted therapies are improving outcomes, it is not uncommon for many patients to have only a partial response, and relapse during follow-up. Thus, new drugs or reevaluation of existing therapies used to treat other non-malignant diseases (drug repurposing) are still needed. While this research both in vitro and in vivo is being carried [...]

Lire la suite